How do I convert 21 units of lispro (insulin lispro) to NPH (neutral protamine Hagedorn) insulin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Converting Insulin Lispro to NPH Insulin

When converting 21 units of insulin lispro to NPH insulin, use a conversion ratio of 80% of the lispro dose, resulting in approximately 17 units of NPH insulin.

Conversion Principles

  • When converting from a rapid-acting insulin (lispro) to an intermediate-acting insulin (NPH), the total daily dose should be reduced to approximately 80% of the original dose due to differences in pharmacokinetic profiles 1
  • For a dose of 21 units of lispro, the equivalent NPH dose would be approximately 17 units (21 × 0.8 = 16.8, rounded to 17) 1
  • NPH insulin has a delayed onset and longer duration of action compared to lispro, requiring dose adjustments to prevent hypoglycemia 1

Administration Considerations

  • Unlike lispro which is administered immediately before meals, NPH insulin should be administered 30-45 minutes before meals due to its delayed onset of action 1
  • Consider splitting the NPH dose into morning and evening injections (2/3 morning, 1/3 evening) for better 24-hour coverage 1
  • Morning administration of NPH is particularly effective for managing daytime hyperglycemia 2, 3

Dosing Adjustments

  • Start with the calculated dose of 17 units and titrate by 2 units every 3 days until the target blood glucose is achieved without hypoglycemia 1
  • Monitor blood glucose levels closely after conversion, particularly fasting and pre-meal values 1
  • If hypoglycemia occurs, reduce the NPH dose by 10-20% (approximately 2-3 units) 1

Special Considerations

  • NPH has a peak effect at 4-6 hours after administration, which differs significantly from lispro's rapid peak at 1 hour 1
  • The pharmacodynamic profile of NPH makes it particularly suitable for covering basal insulin needs and addressing post-meal hyperglycemia that occurs several hours after eating 1, 3
  • For patients requiring mealtime coverage, consider adding a small dose of rapid-acting insulin before meals if postprandial glucose remains elevated 1

Common Pitfalls to Avoid

  • Avoid direct unit-for-unit conversion between lispro and NPH due to their different pharmacokinetic profiles 1
  • Be aware that NPH has a higher risk of nocturnal hypoglycemia compared to rapid-acting insulins like lispro 1
  • Remember that NPH insulin requires resuspension before administration (roll, don't shake the vial) to ensure proper dosing 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Hyperglycemia in Post-Kidney Transplant Patients on High-Dose Steroids

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Steroid-Induced Hyperglycemia with NPH Insulin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.